$239 Million is the total value of PURA VIDA INVESTMENTS, LLC's 69 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SGYPQ | Exit | SYNERGY PHARMACEUTICALS DELcall | $0 | – | -100,000 | -100.0% | -0.08% | – |
| MEIP | Exit | MEI PHARMA INCcall | $0 | – | -196,500 | -100.0% | -0.15% | – |
| STML | Exit | STEMLINE THERAPEUTICS INC | $0 | – | -60,000 | -100.0% | -0.20% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -150,000 | -100.0% | -0.23% | – |
| Exit | INTEC PHARMA LTD JERUSALEM | $0 | – | -100,000 | -100.0% | -0.26% | – | |
| ESRX | Exit | EXPRESS SCRIPTS HLDG COcall | $0 | – | -15,000 | -100.0% | -0.28% | – |
| RGNX | Exit | REGENXBIO INC | $0 | – | -33,920 | -100.0% | -0.33% | – |
| EXEL | Exit | EXELIXIS INCcall | $0 | – | -50,600 | -100.0% | -0.36% | – |
| QDEL | Exit | QUIDEL CORPput | $0 | – | -28,000 | -100.0% | -0.36% | – |
| COLL | Exit | COLLEGIUM PHARMACEUTICAL INC | $0 | – | -117,131 | -100.0% | -0.36% | – |
| AGRX | Exit | AGILE THERAPEUTICS INC | $0 | – | -289,501 | -100.0% | -0.38% | – |
| RVNC | Exit | REVANCE THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.40% | – |
| Exit | SPECTRUM PHARMACEUTICALS INCnote 2.750%12/1 | $0 | – | -10,000 | -100.0% | -0.42% | – | |
| SVRA | Exit | SAVARA INC | $0 | – | -173,023 | -100.0% | -0.47% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INCput | $0 | – | -35,200 | -100.0% | -0.50% | – |
| MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -25,000 | -100.0% | -0.50% | – |
| PTCT | Exit | PTC THERAPEUTICS INCcall | $0 | – | -102,800 | -100.0% | -0.60% | – |
| ZGNX | Exit | ZOGENIX INCcall | $0 | – | -62,600 | -100.0% | -0.64% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.66% | – |
| QGEN | Exit | QIAGEN NVcall | $0 | – | -80,000 | -100.0% | -0.74% | – |
| DXCM | Exit | DEXCOM INCcall | $0 | – | -55,000 | -100.0% | -0.79% | – |
| INSM | Exit | INSMED INC | $0 | – | -87,601 | -100.0% | -0.80% | – |
| BRKS | Exit | BROOKS AUTOMATION INC NEW | $0 | – | -95,000 | -100.0% | -0.84% | – |
| SIEN | Exit | SIENTRA INC | $0 | – | -187,800 | -100.0% | -0.85% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INCcall | $0 | – | -25,000 | -100.0% | -0.88% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INCcall | $0 | – | -200,000 | -100.0% | -0.88% | – |
| FPRX | Exit | FIVE PRIME THERAPEUTICS INCcall | $0 | – | -75,000 | -100.0% | -0.90% | – |
| ONCE | Exit | SPARK THERAPEUTICS INC | $0 | – | -37,589 | -100.0% | -0.98% | – |
| PRAH | Exit | PRA HEALTH SCIENCES INC | $0 | – | -45,000 | -100.0% | -1.00% | – |
| Exit | NABRIVA THERAPEUTICS PLC | $0 | – | -425,000 | -100.0% | -1.02% | – | |
| EW | Exit | EDWARDS LIFESCIENCES CORPcall | $0 | – | -35,000 | -100.0% | -1.12% | – |
| ABT | Exit | ABBOTT LABScall | $0 | – | -75,000 | -100.0% | -1.17% | – |
| ADMS | Exit | ADAMAS PHARMACEUTICALS INCcall | $0 | – | -200,000 | -100.0% | -1.24% | – |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -275,000 | -100.0% | -1.30% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -29,900 | -100.0% | -1.33% | – |
| QDEL | Exit | QUIDEL CORP | $0 | – | -110,000 | -100.0% | -1.41% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -50,000 | -100.0% | -1.71% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -120,000 | -100.0% | -1.72% | – |
| BIO | Exit | BIO RAD LABS INCcl a | $0 | – | -28,000 | -100.0% | -1.82% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB COcall | $0 | – | -100,000 | -100.0% | -1.86% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -35,000 | -100.0% | -2.10% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -80,000 | -100.0% | -2.26% | – |
| BAX | Exit | BAXTER INTL INCput | $0 | – | -135,000 | -100.0% | -2.48% | – |
| MRK | Exit | MERCK & CO. INC | $0 | – | -154,570 | -100.0% | -2.90% | – |
| PFE | Exit | PFIZER INCcall | $0 | – | -500,000 | -100.0% | -5.22% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -100,000 | -100.0% | -7.35% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-02-11
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICU MED INC | 27 | Q2 2024 | 4.2% |
| NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
| LIVANOVA PLC | 26 | Q2 2024 | 3.8% |
| VIEWRAY INC | 25 | Q2 2023 | 3.2% |
| ESTABLISHMENT LABS HLDGS INC | 24 | Q2 2024 | 6.6% |
| INSPIRE MED SYS INC | 24 | Q1 2024 | 3.7% |
| ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
| DEXCOM INC | 23 | Q1 2024 | 1.7% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
| INVACARE CORP | 22 | Q3 2021 | 2.8% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Apyx Medical Corp | February 14, 2024 | 80,000 | 0.2% |
| Lyra Therapeutics, Inc. | February 14, 2024 | 1,613,844 | 3.1% |
| NanoString Technologies IncSold out | February 14, 2024 | 0 | 0.0% |
| Oncocyte Corp | February 14, 2024 | 708,172 | 8.4% |
| Quanterix Corp | February 14, 2024 | 1,935,441 | 5.2% |
| Sonendo, Inc. | February 14, 2024 | 5,422,384 | 10.0% |
| ViewRay, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| CUTERA INC | December 29, 2023 | 1,270,494 | 6.4% |
| Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
| ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-29 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.